| Title |
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research
|
|---|---|
| Published in |
Journal of Cancer Survivorship, July 2014
|
| DOI | 10.1007/s11764-014-0374-2 |
| Pubmed ID | |
| Authors |
Julia R. Van Liew, Alan J. Christensen, Janet S. de Moor |
| Abstract |
For patients with hormone receptor positive breast cancer, survivorship entails prolonged self-management of adjuvant treatment in the form of daily hormone therapy. Although sustained daily adherence across the 5-year course of therapy is associated with improved recurrence-free survival outcomes, adherence is suboptimal and many women discontinue hormone therapy prematurely. Factors associated with breast cancer survivors' nonadherence and nonpersistence are not comprehensively understood. Furthermore, psychosocial variables have only received limited research attention, despite their documented relationships with adherence in other chronic illness populations. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 107 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 17% |
| Researcher | 17 | 15% |
| Student > Master | 11 | 10% |
| Student > Bachelor | 11 | 10% |
| Student > Doctoral Student | 10 | 9% |
| Other | 15 | 14% |
| Unknown | 28 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 26 | 23% |
| Medicine and Dentistry | 18 | 16% |
| Nursing and Health Professions | 16 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Social Sciences | 5 | 5% |
| Other | 10 | 9% |
| Unknown | 29 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2014.
All research outputs
#18,374,472
of 22,758,248 outputs
Outputs from Journal of Cancer Survivorship
#842
of 965 outputs
Outputs of similar age
#163,312
of 227,688 outputs
Outputs of similar age from Journal of Cancer Survivorship
#13
of 16 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 965 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,688 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.